Alerts will be sent to your verified email
Verify Email
BACPHAR
|
Bacil Pharma
|
Bandaram Pharma Pack
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-69.0 % | 5.64 % | 12.26 % |
|
5yr average Equity Multiplier
|
1.36 | 4.09 | 2.68 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.98 | 0.93 |
|
5yr Avg Net Profit Margin
|
0.0 | 1.46 % | 5.75 % |
|
Price to Book
|
1.78 | 3.59 | 1.02 |
|
P/E
|
74.63 | 227.11 | 12.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 185.52 Days | 138.58 Days |
|
Inventory Days
|
0.0 | 58.64 Days | 96.42 Days |
|
Days Receivable
|
0.0 | 164.3 Days | 135.23 Days |
|
Days Payable
|
0.0 | 29.07 Days | 103.44 Days |
|
5yr Average Interest Coverage Ratio
|
-943.72 | 2.12 | 4.03 |
|
5yr Avg ROCE
|
-75.56 % | 8.53 % | 17.72 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 7.35 % | 10.31 % |
|
5 yr average Debt to Equity
|
0.05 | 2.33 | 0.9 |
|
5yr CAGR Net Profit
|
n/a | 16.17 % | 50.43 % |
|
5yr Average Return on Assets
|
-70.2 % | 1.43 % | 5.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.08 % | 75.0 % | 67.47 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-42.59 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bacil Pharma
|
Bandaram Pharma Pack
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|